• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-23A
Device Problems Obstruction of Flow (2423); Material Split, Cut or Torn (4008)
Patient Problems Aortic Valve Stenosis (1717); Chest Pain (1776); Heart Failure (2206)
Event Date 07/25/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2013, a 23mm sjm trifecta valve was implanted in the patient's aortic position due to aortic stenosis and calcification of the patient's congenital aortic bicuspid valve.An abbott sizer was used in the surgery and the trifecta valve was successfully implanted with non-everting mattress suture technique using pledgets.During a follow-up in (b)(6) 2020, there was no problem found in the echocardiogram examination.In mid (b)(6) 2020, the patient presented to the hospital complaining of chest pain and the heart failure was treated by medication.However, the patient's symptom worsened and severe aortic stenosis was confirmed on (b)(6) 2020.An emergency re-do avr was performed on the same date, and the trifecta valve was explanted and replaced with a 21mm edwards intuity elite valve system(by edwards lifesciences).After opening the patient's chest, a vertical tear from the middle of the lcc and the ncc stent post leading to nadir was confirmed visually, thus the surgeon attributed the issue to the leaflet tear of the trifecta valve.The patient is recovering well post-operatively.
 
Manufacturer Narrative
This report is submitted under the incorrect manufacturing report number.The correct manufacturing report number is (b)(4).Explant was reported due to chest pain, stenosis, and heart failure.The investigation confirmed that leaflets 2 and 3 were torn.Circumferential fibrous pannus ingrowth was present, which narrowed the inflow diameter.No inflammation or significant calcifications were present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.In the absence of any calcification or evidence for infection, the reported event is consistent with a non-calcific leaflet tear.A non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.In this case, histological evaluation did not demonstrate loss of collagen at the tear site.The implanted trifecta valve size (23 mm) being larger than the replacement valve (21 mm) and the pannus formation noted is possible evidence of oversizing.The oversizing would have the potential to induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA)
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
MDR Report Key10500078
MDR Text Key205887574
Report Number3008452825-2020-00439
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05414734052030
UDI-Public05414734052030
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Replace
Type of Report Initial,Followup
Report Date 11/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/19/2015
Device Model NumberTF-23A
Device Catalogue NumberTF-23A
Device Lot Number4127373
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/31/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/13/2020
Initial Date FDA Received09/07/2020
Supplement Dates Manufacturer Received10/23/2020
Supplement Dates FDA Received11/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
-
-